Acadian Asset Management LLC Acorda Therapeutics Inc Transaction History

Acadian Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.53 $9 - $16	-32 Reduced -0.0%	682,638 $203,000
Q2 2022 Aug 09, 2022	BUY	$0.3 - $1.67 $64,479 - $358,934	214,931 Added 45.95%	682,670 $318,000
Q4 2021 Feb 10, 2022	BUY	$2.3 - $4.71 $196,270 - $401,927	85,335 Added 22.32%	467,739 $1.12 Million
Q3 2021 Nov 12, 2021	BUY	$3.36 - $4.79 $8,339 - $11,888	2,482 Added 0.65%	382,404 $1.76 Million
Q1 2021 May 11, 2021	BUY	$3.8 - $8.04 $1.44 Million - $3.05 Million	379,922 New	379,922 $1.85 Million

133K

Ticker ACOR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 24,338,400
Market Cap $6.33M
Description
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral drug to improve walking in patients with multiple sclerosis (MS); and Inbrija for the treatment of OFF periods in Parkinson's disease in Europe. It also...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.